Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 6, 2026
Reporting Period: Second Quarter 2026
This filing serves as a notification that the Company issued a press release on August 6, 2026, disclosing its financial results for the second quarter of 2026. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific financial data. The filing explicitly states that the detailed financial results are contained within the press release (Exhibit 99.1), which is furnished but not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
- Revenue, Profit, Cash Flow, Margins: Not provided in the filing text.
- Debt and Liquidity: Not provided in the filing text.
Material Changes
The filing text does not provide specific numerical comparisons or material changes versus the prior comparable period. It only confirms the issuance of the Q2 2026 results.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The text does not include specific guidance or outlook statements; these are referenced as being part of the attached press release.
Risks and Contingencies: No specific risks or contingencies are detailed in this document. The filing includes standard legal disclaimers regarding the "furnished" status of the exhibit.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 6, 2026) for actual revenue, net income, and cash flow figures.
- Verify the specific details of the second quarter 2026 performance, as this 8-K only acts as a notification of the release.
- Confirm whether the press release includes updated forward-looking guidance or operational milestones.